MedTrace Logo

Study of Metformin Overdose

NCT04762966 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2021-02-21

No results posted yet for this study

Summary

The objective of the METINFO study is an observational single-center retrospective and descriptive study. The main objective is to estimate the real mortality rate associated to a Metformin overdose. Second objectives are to estimate the real hospitalization rate related to metformin overdose and to identify the risk factors of a metformin overdose and especially the potential correlation between metformin blood concentration and overdose severity.

Conditions

  • Metformin Associated Lactic Acidosis

Interventions

DRUG

Metformin

Level of Metformin blood concentration

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2021-08-01
Completion
2021-09-01

Countries

  • France

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04762966 on ClinicalTrials.gov